Cocktail of Glaxo's AZT data

Preliminary results of an NIH-supported trial, ACTG 315, show that three months of treatment with a combination of anti-retroviral agents may restore partial

Read the full 235 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE